Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225892528> ?p ?o ?g. }
- W4225892528 abstract "PURPOSE Soft tissue and bone sarcomas are rare malignancies that exhibit significant pathologic and molecular heterogeneity. Deregulation of the CDKN2A-CCND-CDK4/6-retinoblastoma 1 (Rb) pathway is frequently observed in about 25% of unselected sarcomas and is pathognomonic for specific sarcoma subtypes. This genomic specificity has fueled the clinical evaluation of selective CDK4/6 inhibitors in sarcomas. Here, we highlight successes, opportunities, and future challenges for using CDK4/6 inhibitors to treat sarcoma. MATERIALS AND METHODS This review summarizes the current evidence for the use of CDK4/6 inhibitors in sarcoma while identifying molecular rationale and predictive biomarkers that provide the foundation for targeting the CDK4/6 pathway in sarcoma. A systematic review was performed of articles indexed in the PubMed database and the National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov). For each sarcoma subtype, we discuss the preclinical rationale, case reports, and available clinical trials data. RESULTS Despite promising clinical outcomes in a subset of sarcomas, resistance to CDK4/6 inhibitors results in highly heterogeneous clinical outcomes. Current clinical data support the use of CDK4/6 inhibitors in subsets of sarcoma primarily driven by CDK4/6 deregulation. When dysregulation of the Rb pathway is a secondary driver of sarcoma, combination therapy with CDK4/6 inhibition may be an option. Developing strategies to identify responders and the mechanisms that drive resistance is important to maximize the clinical utility of these drugs in patients with sarcoma. Potential biomarkers that indicate CDK4/6 inhibitor sensitivity in sarcoma include CDK4, CCND, CCNE, RB1, E2F1, and CDKN2A. CONCLUSION CDK4/6 inhibitors represent a major breakthrough for targeted cancer treatment. CDK4/6 inhibitor use in sarcoma has led to limited, but significant, early clinical success. Targeted future clinical research will be key to unlocking the potential of CDK4/6 inhibition in sarcoma." @default.
- W4225892528 created "2022-05-05" @default.
- W4225892528 creator A5003245399 @default.
- W4225892528 creator A5005257837 @default.
- W4225892528 creator A5028128038 @default.
- W4225892528 creator A5037373285 @default.
- W4225892528 creator A5074791660 @default.
- W4225892528 date "2022-05-01" @default.
- W4225892528 modified "2023-10-01" @default.
- W4225892528 title "Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges" @default.
- W4225892528 cites W1495081722 @default.
- W4225892528 cites W1555334434 @default.
- W4225892528 cites W1566720599 @default.
- W4225892528 cites W1573791879 @default.
- W4225892528 cites W158990098 @default.
- W4225892528 cites W1606749110 @default.
- W4225892528 cites W1890728356 @default.
- W4225892528 cites W1964824855 @default.
- W4225892528 cites W1968836238 @default.
- W4225892528 cites W1975249349 @default.
- W4225892528 cites W1980088710 @default.
- W4225892528 cites W1987085807 @default.
- W4225892528 cites W1988491941 @default.
- W4225892528 cites W1991050083 @default.
- W4225892528 cites W1991172032 @default.
- W4225892528 cites W1994392862 @default.
- W4225892528 cites W1995353076 @default.
- W4225892528 cites W1995827600 @default.
- W4225892528 cites W1996375162 @default.
- W4225892528 cites W2001997645 @default.
- W4225892528 cites W2018310400 @default.
- W4225892528 cites W2020953583 @default.
- W4225892528 cites W2021804432 @default.
- W4225892528 cites W2034176492 @default.
- W4225892528 cites W2041694372 @default.
- W4225892528 cites W2057272791 @default.
- W4225892528 cites W2065773722 @default.
- W4225892528 cites W2071129895 @default.
- W4225892528 cites W2072798629 @default.
- W4225892528 cites W2077149593 @default.
- W4225892528 cites W2091851204 @default.
- W4225892528 cites W2100555004 @default.
- W4225892528 cites W2107480474 @default.
- W4225892528 cites W2108092011 @default.
- W4225892528 cites W2112521155 @default.
- W4225892528 cites W2128560398 @default.
- W4225892528 cites W2134410951 @default.
- W4225892528 cites W2136158663 @default.
- W4225892528 cites W2136930354 @default.
- W4225892528 cites W2157803976 @default.
- W4225892528 cites W2167424472 @default.
- W4225892528 cites W2172754060 @default.
- W4225892528 cites W2187845981 @default.
- W4225892528 cites W2191852401 @default.
- W4225892528 cites W2275069152 @default.
- W4225892528 cites W2284288512 @default.
- W4225892528 cites W2323720192 @default.
- W4225892528 cites W2325428530 @default.
- W4225892528 cites W2343607850 @default.
- W4225892528 cites W2390782195 @default.
- W4225892528 cites W2401425325 @default.
- W4225892528 cites W2410902188 @default.
- W4225892528 cites W2487368057 @default.
- W4225892528 cites W2513801928 @default.
- W4225892528 cites W2520255934 @default.
- W4225892528 cites W2520576659 @default.
- W4225892528 cites W2531209889 @default.
- W4225892528 cites W2568050301 @default.
- W4225892528 cites W2568562831 @default.
- W4225892528 cites W2581955996 @default.
- W4225892528 cites W2592044043 @default.
- W4225892528 cites W2593909874 @default.
- W4225892528 cites W2604733575 @default.
- W4225892528 cites W2617437931 @default.
- W4225892528 cites W2624850365 @default.
- W4225892528 cites W2679430764 @default.
- W4225892528 cites W2759728042 @default.
- W4225892528 cites W2760867470 @default.
- W4225892528 cites W2765468373 @default.
- W4225892528 cites W2765749359 @default.
- W4225892528 cites W2766493195 @default.
- W4225892528 cites W2766564047 @default.
- W4225892528 cites W2774451814 @default.
- W4225892528 cites W2790157952 @default.
- W4225892528 cites W2800934098 @default.
- W4225892528 cites W2804343273 @default.
- W4225892528 cites W2826011608 @default.
- W4225892528 cites W2886803370 @default.
- W4225892528 cites W2890791082 @default.
- W4225892528 cites W2896664662 @default.
- W4225892528 cites W2896920508 @default.
- W4225892528 cites W2898277702 @default.
- W4225892528 cites W2900164991 @default.
- W4225892528 cites W2901637385 @default.
- W4225892528 cites W2904093244 @default.
- W4225892528 cites W2905067827 @default.
- W4225892528 cites W2909174274 @default.
- W4225892528 cites W2921324177 @default.
- W4225892528 cites W2924290536 @default.
- W4225892528 cites W2935550936 @default.